The causal effects between low back pain and cerebrospinal fluid metabolites: a two-sample Mendelian randomization study

Abstract Background Observational studies have shown an association between cerebrospinal fluid (CSF) metabolites and low back pain (LBP), but the causal relationship between these factors remains unclear. Methods We performed a two-sample Mendelian randomization (MR) analysis to examine whether the...

Full description

Saved in:
Bibliographic Details
Main Authors: Run Peng, Xiaoxin Wang, Wei Wang, Zeqin Li, Yuze Sun, Mingliang Yang
Format: Article
Language:English
Published: BMC 2025-02-01
Series:Hereditas
Subjects:
Online Access:https://doi.org/10.1186/s41065-025-00374-y
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823861957031100416
author Run Peng
Xiaoxin Wang
Wei Wang
Zeqin Li
Yuze Sun
Mingliang Yang
author_facet Run Peng
Xiaoxin Wang
Wei Wang
Zeqin Li
Yuze Sun
Mingliang Yang
author_sort Run Peng
collection DOAJ
description Abstract Background Observational studies have shown an association between cerebrospinal fluid (CSF) metabolites and low back pain (LBP), but the causal relationship between these factors remains unclear. Methods We performed a two-sample Mendelian randomization (MR) analysis to examine whether there is a causal relationship between CSF metabolites and LBP. We applied several MR methods, including inverse variance weighting, weighted median, MR-Egger, Wald ratio, and MR-PRESSO, to test the causal relationship and conducted a sensitivity analysis to assess the robustness of the results. Results We identified a total of 12 CSF metabolites significantly associated with LBP, of which Bilirubin, 5,6-dihydrothymine, Erythronate, Mannitol/sorbitol, and Butyrate have a potential inhibitory causal effect on LBP risk (p < 0.05). Meanwhile, 2-hydroxyadipate, Gamma-glutamyl-alpha-lysine, Indoleacetate, N-acetylputrescine, Palmitoyl dihydrosphingomyelin, S-methylcysteine, and 2,3-dihydroxy-5-methylthio-4-pentenoate play a causal role in increasing the risk of LBP (p < 0.05). No significant estimates of heterogeneity or pleiotropy were detected. Conclusion Our study emphasizes the causal relationship between CSF metabolites and LBP risk, providing reference for clinical treatment and prognosis of LBP.
format Article
id doaj-art-46e864a7537e46a1a7bd542a4b6c8ac7
institution Kabale University
issn 1601-5223
language English
publishDate 2025-02-01
publisher BMC
record_format Article
series Hereditas
spelling doaj-art-46e864a7537e46a1a7bd542a4b6c8ac72025-02-09T12:40:01ZengBMCHereditas1601-52232025-02-0116211910.1186/s41065-025-00374-yThe causal effects between low back pain and cerebrospinal fluid metabolites: a two-sample Mendelian randomization studyRun Peng0Xiaoxin Wang1Wei Wang2Zeqin Li3Yuze Sun4Mingliang Yang5School of Rehabilitation Medicine, Capital Medical UniversitySchool of Rehabilitation Medicine, Capital Medical UniversitySchool of Rehabilitation Medicine, Capital Medical UniversitySchool of Rehabilitation Medicine, Capital Medical UniversitySchool of Rehabilitation Medicine, Capital Medical UniversitySchool of Rehabilitation Medicine, Capital Medical UniversityAbstract Background Observational studies have shown an association between cerebrospinal fluid (CSF) metabolites and low back pain (LBP), but the causal relationship between these factors remains unclear. Methods We performed a two-sample Mendelian randomization (MR) analysis to examine whether there is a causal relationship between CSF metabolites and LBP. We applied several MR methods, including inverse variance weighting, weighted median, MR-Egger, Wald ratio, and MR-PRESSO, to test the causal relationship and conducted a sensitivity analysis to assess the robustness of the results. Results We identified a total of 12 CSF metabolites significantly associated with LBP, of which Bilirubin, 5,6-dihydrothymine, Erythronate, Mannitol/sorbitol, and Butyrate have a potential inhibitory causal effect on LBP risk (p < 0.05). Meanwhile, 2-hydroxyadipate, Gamma-glutamyl-alpha-lysine, Indoleacetate, N-acetylputrescine, Palmitoyl dihydrosphingomyelin, S-methylcysteine, and 2,3-dihydroxy-5-methylthio-4-pentenoate play a causal role in increasing the risk of LBP (p < 0.05). No significant estimates of heterogeneity or pleiotropy were detected. Conclusion Our study emphasizes the causal relationship between CSF metabolites and LBP risk, providing reference for clinical treatment and prognosis of LBP.https://doi.org/10.1186/s41065-025-00374-yCerebrospinal fluid metabolitesBiomarkersLow back painMendelian randomizationCausal relationship
spellingShingle Run Peng
Xiaoxin Wang
Wei Wang
Zeqin Li
Yuze Sun
Mingliang Yang
The causal effects between low back pain and cerebrospinal fluid metabolites: a two-sample Mendelian randomization study
Hereditas
Cerebrospinal fluid metabolites
Biomarkers
Low back pain
Mendelian randomization
Causal relationship
title The causal effects between low back pain and cerebrospinal fluid metabolites: a two-sample Mendelian randomization study
title_full The causal effects between low back pain and cerebrospinal fluid metabolites: a two-sample Mendelian randomization study
title_fullStr The causal effects between low back pain and cerebrospinal fluid metabolites: a two-sample Mendelian randomization study
title_full_unstemmed The causal effects between low back pain and cerebrospinal fluid metabolites: a two-sample Mendelian randomization study
title_short The causal effects between low back pain and cerebrospinal fluid metabolites: a two-sample Mendelian randomization study
title_sort causal effects between low back pain and cerebrospinal fluid metabolites a two sample mendelian randomization study
topic Cerebrospinal fluid metabolites
Biomarkers
Low back pain
Mendelian randomization
Causal relationship
url https://doi.org/10.1186/s41065-025-00374-y
work_keys_str_mv AT runpeng thecausaleffectsbetweenlowbackpainandcerebrospinalfluidmetabolitesatwosamplemendelianrandomizationstudy
AT xiaoxinwang thecausaleffectsbetweenlowbackpainandcerebrospinalfluidmetabolitesatwosamplemendelianrandomizationstudy
AT weiwang thecausaleffectsbetweenlowbackpainandcerebrospinalfluidmetabolitesatwosamplemendelianrandomizationstudy
AT zeqinli thecausaleffectsbetweenlowbackpainandcerebrospinalfluidmetabolitesatwosamplemendelianrandomizationstudy
AT yuzesun thecausaleffectsbetweenlowbackpainandcerebrospinalfluidmetabolitesatwosamplemendelianrandomizationstudy
AT mingliangyang thecausaleffectsbetweenlowbackpainandcerebrospinalfluidmetabolitesatwosamplemendelianrandomizationstudy
AT runpeng causaleffectsbetweenlowbackpainandcerebrospinalfluidmetabolitesatwosamplemendelianrandomizationstudy
AT xiaoxinwang causaleffectsbetweenlowbackpainandcerebrospinalfluidmetabolitesatwosamplemendelianrandomizationstudy
AT weiwang causaleffectsbetweenlowbackpainandcerebrospinalfluidmetabolitesatwosamplemendelianrandomizationstudy
AT zeqinli causaleffectsbetweenlowbackpainandcerebrospinalfluidmetabolitesatwosamplemendelianrandomizationstudy
AT yuzesun causaleffectsbetweenlowbackpainandcerebrospinalfluidmetabolitesatwosamplemendelianrandomizationstudy
AT mingliangyang causaleffectsbetweenlowbackpainandcerebrospinalfluidmetabolitesatwosamplemendelianrandomizationstudy